| CBG | capillary blood gases; coronary bypass graft; corticosteroid-binding globulin; cortisol-binding glob... |
|---|---|
| IBC | Institutional Biosafety Committee; iodine-binding capacity; iron-binding capacity; isobutyl cyanoacr... |
| TBA | tertiary butylacetate; testosterone-binding affinity; tetrabutylammonium; thiobarbituric acid; to be... |
| TBI | thyroid-binding index; thyroxine-binding index; tooth-brushing instruction; total-body irradiation; ... |
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
hypophosphatemic rickets (저인산 혈성 구루병, 저인산염 혈성 구루병
| placental growth hormone | human placental lactogen |
|---|---|
| plant growth regulators | Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (12 Dec 1998) |
| plant growth substances | <plant biology> Substances that, at low concentration, influence plant growth and differentiation. Formerly referred to as plant hormones or phytohormones, these terms are now suspect because some aspects of the hormone concept, notably action at a distance from the site of synthesis, do not necessarily apply in plants. Also called plant growth regulators. The major classes are absicisic acid, auxin, cytokinin, ethylene and gibberellin, others include steroid and phenol derivatives. (31 Dec 1997) |
| multiplicative growth | Growth by an increase in the number of cells. (05 Mar 2000) |
| contact inhibition of growth | See: density dependent inhibition. (18 Nov 1997) |
| population growth | <epidemiology> Increase, over a specific period of time, in the number of individuals living in a country or region. (12 Dec 1998) |
| haematopoietic cell growth factors | These growth factors comprise a family of haematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. Erythropoietin and the colony-stimulating factors belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes. (12 Dec 1998) |
| second growth | A second generation of timber of merchantable age. (05 Dec 1998) |
| horizontal growth phase | An early stage of development of cutaneous melanoma by intraepidermal spread of atypical melanocytes. (05 Mar 2000) |
| human growth hormone | <endocrinology> A protein produced in the pituitary gland that stimulates the liver to produce somatomedins, which stimulate growth of bone and muscle. (09 Oct 1997) |
| stem cell growth factors | <growth factor> Compounds, usually proteins, that make stem cells grow faster. (26 Mar 1998) |
| nerve growth cone | <cell biology> A specialised region at the tip of a growing neurite that is responsible for sensing the local environment and moving toward the neuron's target cell. Growth cones are hand shaped, with several long filopodia that differentially adhere to surfaces in the embryo. Growth cones can be sensitive to several guidance cues, for example: surface adhesiveness, growth factors, neurotransmitters and electric fields (galvanotropism). (18 Nov 1997) |
| nerve growth factors | Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. (12 Dec 1998) |
| new growth | <oncology, pathology> New and abnormal growth of tissue, which may be benign or cancerous. (16 Dec 1997) |
| density dependent inhibition of growth | <cell culture> The phenomenon exhibited by most normal (anchorage dependent) animal cells in culture that stop dividing once a critical cell density is reached. The critical density is considerably higher for most cells than the density at which a monolayer is formed, for this reason, most cell behaviourists prefer the term density dependent inhibition of growth as this avoids any confusion with contact inhibition of locomotion, a totally different phenomenon that is contact dependent. (12 Jan 1998) |